OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-ZB21         View EO 12866 Meetings Received Date: 06/21/2022 
Title: Drug Supply Chain Security Act Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs; Draft Guidance for Industry; Availability 
Agency/Subagency: HHS / FDA   Stage: Notice 
Concluded Action: Consistent without Change  Concluded Date: 06/24/2022 
Legal Deadline: None  Economically Significant: No 
Publication Date:   Unfunded Mandates: No 
Major: No  Related To Homeland Security: No 
Regulatory Flexibility Analysis Required: No  Small Entities Affected: No 
Federalism Implications: No  Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No